Publication | Closed Access

Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial

Translational MedicinePulmonary TuberculosisTuberculosis PreventionImmunologyAdjunct TreatmentTranslational ResearchTuberculosisSafety TrialDrug-resistant TuberculosisMedicineCell Transplantation